Epilepsy, psychosis and clozapine
β Scribed by J. M. Langosch; M. R. Trimble
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 54 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0885-6222
- DOI
- 10.1002/hup.375
No coin nor oath required. For personal study only.
β¦ Synopsis
Six patients with epilepsy and severe psychosis were treated with the atypical antipsychotic clozapine. The use of clozapine might be complicated in epileptic patients because of an increased risk of seizures. However, none of the reported patients had an increase of their seizure frequency, in contrast, three patients had a substantial reduction of seizures. One patient had a reduction of non-epileptic seizures as well. In the second part of this paper, combinations of clozapine with newer and older anticonvulsants as well as their interactions and associated risks are discussed.
π SIMILAR VOLUMES
## Abstract The clinical efficacy of clozapine, an atypical antipsychotic, in treating levodopaβinduced hallucinations was investigated in five patients with Parkinson's disease under open label conditions. Two patients could not tolerate clozapine, even in doses as low as 12.5β25 mg daily, because
Objective. The objective was to analyze outcome of clozapine therapy in elderly patients with treatment refractory primary psychosis. Design. This was an open-label clozapine trial in elderly patients. Patient psychopathology was assessed before and after clozapine therapy. Setting. A psychiatry s